Loading organizations...
§ Private Profile · Maastricht, Limburg, The Netherlands
Developer and supplier of clinically tested, plant-based health ingredients and polyphenols for dietary supplements and functional foods.
BioActor is a Maastricht, Netherlands-based biotechnology company that develops and commercializes clinically evaluated, plant-based active health ingredients for the dietary supplements and functional foods industries. The enterprise specializes in extracting and validating natural polyphenols from edible plants and fruits to support cognitive function, physical performance, women's health, and healthy aging. Operating as a business-to-business ingredient supplier from the Maastricht Health Campus, the organization exports its proprietary compounds to manufacturers and supplement brands across more than 20 countries worldwide. In January 2023, the French multinational Solabia Group, led by chief executive officer Jean-Baptiste Dellon, acquired a majority stake in the business to expand its nutrition division and scale global production. The company's portfolio of patented and clinically backed ingredient brands includes Brainberry, Watts'Up, and Bonolive. BioActor was founded in 2011 by Hans van der Saag.
BioActor has raised $2.9M across 1 funding round.
BioActor has raised $2.9M in total across 1 funding round.
BioActor has raised $2.9M in total across 1 funding round.
BioActor's investors include Hans van der Saag, ICOS Capital, Limburg Ventures, Nedermaas Hightech Ventures.
BioActor has raised $2.9M across 1 funding round. Most recently, it raised $2.9M Series A in July 2011.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jul 26, 2011 | $2.9M Series A | — | Hans VAN DER Saag, ICOS Capital, Limburg Ventures, Nedermaas Hightech Ventures | Announced |